SCHEMBL18763979

SCHEMBL18763979

CC(C)(C)c1cc(C2=CCc3ccccc32)cc(C(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
PLA2G1B P04054 1/20 0.36
NFKB1 P19838 1/20 0.36
CASP3 P42574 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
RXRA P19793 3/20 0.35
RXRB P28702 3/20 0.35
RXRG P48443 2/20 0.34
PTPN1 P18031 1/20 0.34
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30143246 0.86 S1PR1 (0.38) NPC1ALDH1A1PLA2G1BNFKB1CASP3
SCHEMBL18763972 0.86 S1PR1 (0.38) NPC1ALDH1A1PLA2G1BNFKB1CASP3
SCHEMBL17293172 0.85 HTR1A (0.41) ALDH1A1RXRARXRBRXRGCYP3A4
SCHEMBL9873789 0.79 MAPT (0.39) NPC1ALDH1A1RAB9AKDM4EMAPT
SCHEMBL18774721 0.79 HTR1A (0.37) ALDH1A1L3MBTL1KDM4EMAPTCYP1A2
SCHEMBL27677983 0.76 CYP3A4 (0.46) NPC1ALDH1A1PLA2G1BNFKB1CASP3
SCHEMBL6942653 0.76 POLB (0.34) RXRARXRBRXRGKDM4EGAA
SCHEMBL29598333 0.75 ALDH1A1 (0.39) NPC1ALDH1A1CASP3RAB9ASENP8
SCHEMBL170839 0.75 ALDH1A1 (0.39) NPC1ALDH1A1CASP3RAB9ASENP8
SCHEMBL6198719 0.71 ALDH1A1 (0.43) NPC1ALDH1A1NFKB1RAB9ANFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148937-B1 METALLIC COMPLEX CATALYST AND POLYMERIZATION METHODS EMPLOYING SAME BRIDGESTONE CORP (JP) 2019-09-18 EP disclosed
US-10017595-B2 Metallic complex catalyst and polymerization methods employing same BRIDGESTONE CORPORATION (JP) 2018-07-10 US disclosed
US-20170114171-A1 Metallic Complex Catalyst And Polymerization Methods Employing Same BRIDGESTONE CORPORATION (JP) 2017-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170114171-A1 Metallic Complex Catalyst And Polymerization Methods Employing Same C5, C1S, C9 NPC1 4008/4885ALDH1A1 1981/4885PLA2G1B 974/4885
US-10017595-B2 Metallic complex catalyst and polymerization methods employing same C5, C1S, C9 NPC1 4008/4885ALDH1A1 1981/4885PLA2G1B 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.